Trial Profile
A Prospective, Observational Study to Investigate the Newly Initiated Anticoagulation with Dabigatran Versus Uninterrupted Vitamin K Antagonist Therapy in Patients with Atrial Fibrillation Scheduled for Transesophageal Echocardiogram (TEE)-Guided Direct Electrical Current Cardioversion (DCC)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Sep 2018
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Vitamin K antagonists
- Indications Embolism; Stroke; Thrombosis
- Focus Adverse reactions; Therapeutic Use
- 20 Sep 2018 New trial record